Back to search

Article

Mitochondrial Aconitase enzymatic activity: a potential long survival biomarker in the blood of ALS patients

2023-01-24

Abstract excerpt

<h4>Background: </h4> Amyotrophic Lateral Sclerosis (ALS) is a multisystemic, progressive, neurodegenerative disorder. Despite it being generally fatal within a period of 2–4 years, it is highly heterogeneous; as a result, survival periods may vary greatly among individual patients. In the absence of a single reliable test for ALS, Biomarkers can serve as tools for diagnosis, prognosis, indicators of therapeutic r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7cc56898-df05-5e2b-a7fc-34a5934e3c85
DOI
10.21203/rs.3.rs-2480485/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mitochondrial Aconitase enzymatic activity: a potential long survival biomarker in the blood of ALS patientsDOI 10.21203/rs.3.rs-2480485/v1
Select a neighboring publication to make it the new centre.